Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Sarcopenia is Associated with Postoperative Complications in Patients Undergoing D2 Gastrectomy for Gastric Cancer
    Alemdar, Ali
    Bahadir, Ozgur
    Bayraktarli, Recep Yilmaz
    Onol, Suzan Deniz
    Yilmaz, Ismail
    Kamali, Sedat
    Egin, Seracettin
    Duman, Mehmet Guray
    BEZMIALEM SCIENCE, 2023, 11 (01): : 113 - 119
  • [32] Recurrence risk factors for advanced gastric cancer after D2 gastrectomy followed by adjuvant chemotherapy
    Hwang, Jun-Eul
    Kim, Min-Jee
    Shim, Hyun-Jeong
    Bae, Woo-Kyun
    Cho, Sang-Hee
    Chung, Ik-Joo
    CANCER RESEARCH, 2014, 74 (19)
  • [33] The effect and safety of laparoscopic D2 radical gastrectomy for advanced gastric cancer
    Ji, Hong
    Zhang, Yafei
    Li, Yiming
    Lu, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (01): : 282 - 287
  • [34] Laparoscopic D2 distal gastrectomy for advanced gastric cancer: a myth or a reality?
    Memon, Muhammed Ashraf
    Memon, Breda
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 1
  • [35] Laparoscopic Total Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer
    Shinohara, Toshihiko
    Kanaya, Seiichiro
    Taniguchi, Keizo
    Fujita, Tetsuji
    Yanaga, Katsuhiko
    Uyama, Ichiro
    ARCHIVES OF SURGERY, 2009, 144 (12) : 1138 - 1142
  • [36] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [37] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy
    Wang, Shu-Bei
    Qi, Wei-Xiang
    Chen, Jia-Yi
    Xu, Cheng
    Kirova, Youlia M.
    Cao, Wei-Guo
    Cai, Rong
    Cao, Lu
    Yan, Min
    Cai, Gang
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [40] Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy
    Shu-Bei Wang
    Wei-Xiang Qi
    Jia-Yi Chen
    Cheng Xu
    Youlia M. Kirova
    Wei-Guo Cao
    Rong Cai
    Lu Cao
    Min Yan
    Gang Cai
    Radiation Oncology, 14